Multidisciplinary Perspectives on OSA Treatment with Inspire for CPAP-intolerant Patients
Panelists discuss proper patient selection, preparation for device evaluation and the procedure, and post-implant adjustments.
Category: Neurostimulators
Neurostimulators
Latest
Neurostimulators
LatestHumana Now Provides Coverage for Inspire Upper Airway Stimulation
Health plan provider Humana Inc will provide coverage for Inspire upper airway stimulation therapy, effective August 27.
Neurostimulators
Popular
Which Patients Are Good Candidates for Inspire Upper Airway Stimulation?
As the first FDA-cleared fully implanted neurostimulation device for obstructive sleep apnea becomes available in additional cities throughout the United States, Sleep Review provides guidance on how to screen patients for this therapy.
3 MACs Expected to Release Final Inspire Therapy Coverage Decisions on March 15
Three Medicare Administrative Contractors (MACs) have announced the effective release date of March 15, 2020, for their final local coverage determinations (LCD) policies covering Inspire Medical Systems Inc’s Inspire...
Read More![30-Minute Ask Us Anything: Inspire Medical Systems Inc [On-Demand Webinar]](https://www.sleepreviewmag.com/wp-content/uploads/2020/01/InspireRemote-627x376.png)
30-Minute Ask Us Anything: Inspire Medical Systems Inc [On-Demand Webinar]
Two expert physician panelists answer audience questions about Inspire Medical Systems Inc, the makers of upper airway stimulation therapy for obstructive sleep apnea.
Read More
Investigational Nerve Stimulator for Obstructive Sleep Apnea: Surgical Technique Description and Case Study Report Published
Data demonstrating the benefits and safety of Nyxoah SA’s Genio hypoglossal nerve...
Read More
Medicare Contractors Support Use of Inspire’s Sleep Apnea Device
Inspire Medical Systems, Inc, a medical technology company focused on the development and...
Read MoreOhio’s Kettering Medical Sleep Center Offers Alternative Treatment for Sleep Apnea
The Kettering Medical Sleep Center is offering Inspire, a device that’s implanted under the skin of the neck and chest during an outpatient procedure to treat obstructive sleep apnea. The device is controlled by a small,...
Read More
Inspire Medical Systems Launches New Brand Identity and Website
Inspire Medical Systems Inc, a medical technology company focused on the development and...
Read More
Treatment Benefits of Remedē System Sustained Through 36 Months in Patients with Central Sleep Apnea
Newly published results from 24- and 36-month data from the remed? System Pivotal Trial...
Read More
Toward a Better Understanding of Sleep Surgery
The international sleep medicine community gathered in New York City to discuss hypoglossal...
Read MoreUnited HealthCare to Cover Inspire Sleep Apnea Implant Effective Aug 1
Inspire Medical Systems Inc, a medical technology company that makes an implantable therapy for obstructive sleep apnea (OSA) and is focused on the development and commercialization of minimally invasive solutions for patients...
Read More
2 Sleep Entrepreneurs Recognized in Regional Heartland Awards
Assurance, tax, transaction and advisory services company EY announced the winners of its...
Read More
Company Closes Series 2 Funding Round for Continued Development of Daytime Neurostimulator for Snoring, Mild Sleep Apnea
Signifier Medical Technologies, which is developing the “Snoozeal” daytime...
Read More
Therapy Update: Implanted Neurostimulators for Sleep Apnea
Inspire Medical, Respicardia, LivaNova, and Nyxoah share the latest data on their devices.
Read More
More Positive Payor Determinations for Inspire Therapy, Including Additional 10.4 Million Covered Lives
Inspire Medical Systems Inc, a medical technology company that makes an implantable therapy for...
Read More
Upper Airway Stimulation’s Impact on Sleep Apnea Comorbidities
The Inspire implant has been shown to improve sleepiness and functional outcomes. Now researchers...
Read MoreNyxoah Gets European CE Mark Approval for Sleep Apnea Hypoglossal Nerve Stimulation System
Nyxoah SA has received CE Mark approval for the Genio system in Europe. The Genio system is a battery-free, leadless and minimally invasive neurostimulator, capable of delivering bilateral hypoglossal nerve stimulation for...
Read More